Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Pharm Res. 2011 Sep 27;29(3):707–721. doi: 10.1007/s11095-011-0596-1

Fig. 5.

Fig. 5

Particle trajectories contoured based on diameter growth ratio for the budesonide:CA aerosol generated using the (a) CAG and (b) Respimat inhaler. The bolus delivery of the Respimat inhaler appears to reduce the growth ratio by a negligible amount.